Epworth Freemasons
Melbourne, Victoria 3002
2 studies enrolling now · 3 studies all time
What they study most
Multiple Myeloma, Ovarian Cancer
Studies at this site
- A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant — Recruiting now
- Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM) — Recruiting now
- Circulating Tumour DNA as a Marker of Residual Disease & Response to Adjuvant Chemotherapy in Stage I-IV Ovarian Cancer — Status unconfirmed